restructuring

red and yellow background with scissors

Pharma

Narcan maker Emergent axes top R&D post in sweeping restructuring

In a bold move, Emergent will eliminate the role of head of R&D as part of a layoff round across all areas of the company.

Angus Liu Aug 5, 2026 8:16pm

Bayer Bill Anderson

Bayer CEO Anderson sticking out firm's revitalization scheme

Aug 4, 2026 10:40am

Miels

GSK CEO targets mature products, procurement for cost savings

Jul 28, 2026 9:45am

Layoffs

ADC plots 17% staff cuts amid Zynlonta safety concerns

Jun 24, 2026 10:19am

Astellas

Inside Astellas CEO's plan to counter Xtandi's patent cliff

Jun 11, 2026 6:00pm

Takeda

Takeda's $1.3B savings drive to impact 4,500 roles in '26

May 13, 2026 11:41am